Lifestyle

MHRA Launches New Programme to Address Women's Health Evidence Gaps

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) is launching a new programme to better understand the impact of medicines and medical devices on women's health.

UKTC automated summary1 min read
MHRA Launches New Programme to Address Women's Health Evidence Gaps

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a new initiative to address significant evidence gaps in women's health. Although women comprise 51% of the population, they remain underrepresented in clinical research. An analysis of UK clinical trial applications between 2019 and 2023 revealed that pregnant women were included in only 1.1% of trials, while breastfeeding women appeared in just 0.6%. This new programme aims to improve the quality of data regarding how medicines and medical devices impact women differently, ensuring that healthcare is more accurately tailored to their specific biological needs.

This project serves as a key component of the MHRA's 2030 Strategy, which focuses on mitigating health inequalities. By engaging with patients, researchers, and industry leaders, the agency intends to foster a more inclusive regulatory environment. For members of the UK Turkish community, this means that clinical guidelines and treatments related to reproductive health and long-term conditions may become more evidence-based and responsive. The initiative supports the wider government's Women’s Health Strategy across the UK, aiming for a healthcare system that better reflects the diverse needs of its female population.

The UK's FemTech sector, currently valued at nearly £300 million in annual turnover, stands to benefit from clearer regulatory pathways for new products. By ensuring that safety and efficacy data are gathered more effectively, the MHRA hopes to accelerate the availability of innovative technologies. A webinar is scheduled for 9 December from 11am to 12pm to introduce the programme and discuss future plans. This initiative represents a significant step toward ensuring that medical research becomes more representative, ultimately helping to reduce health inequalities and empowering women to make better-informed decisions regarding their own self-care and medical treatment.

This summary was prepared with AI assistance. Please verify accuracy via the source.

Source: GOV.UK Immigration

000
1 min read

Don't miss the next story

Get an email when new articles are published. Free, and you can unsubscribe at any time.

Share

Comments

Please log in to leave a comment.

Loading comments...